Table 2.

Pathological data

	SURG (n = 32)	TACE (N = 16)	SIRT (N = 12)	P
Tumor differentiation				0.51
Well	10 (31.2%)	5 (31.2%)	3 (25%)
Moderate	18 (56.2%)	10 (62.5%)	6 (50%)
Poorly	4 (12.5%)	1 (6.25%)	3 (25%)
Tumor necrosis				< 0.001
Absence	26 (81.2%)	1 (6.25%)	3 (25%)
Minor (1–25%)	4 (12.5%)	2 (12.5%)	1 (8.3%)
Moderate (25–50%)	2 (6.25%)	3 (18.75%)	2 (16.6%)
Major (> 50%)	0	5 (31.2%)	4 (33.3%)
Complete (100%)	0	5 (31.2%)	2 (16.6%)

SURG surgery, TACE transarterial chemoembolization, SIRT selective internal radiation therapy